Global Gastric Cancer Diagnostic Procedure Market Report 2024

Gastric Cancer Diagnostic Procedure Global Market Report 2024 – By Procedure Type (Endoscopic Procedure, Biopsy, Tissue tests, Lab tests, In-vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types ), By Symptom Type (Symptomatic, Asymptomatic), By Offering Type (Instruments, Reagents and Consumables, Services), By Body Fluid Type (Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid), By Disease Indication (Early Gastric Cancer, Advanced Gastric Cancer) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Gastric Cancer Diagnostic Procedure Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Gastric Cancer Diagnostic Procedure Market Definition And Segments

Gastric cancer diagnostic procedure refers to a technique of identification and medication to treat cancer cells that grow in the stomach. It is used to diagnose stomach cancer.

The main procedures of gastric cancer diagnostic procedure are endoscopic procedure, biopsy, tissue tests, lab tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics, immunoassays, and others. Endoscopic Procedure refers to a process of observing an internal organ, such as the gastrointestinal tract, by inserting a long, thin tube straight into the body. The endoscopy procedure used in gastric cancer for diagnosing stomach cancer. It is suitable for symptoms such as symptomatic and asymptomatic and offers solutions such as instruments, reagents and consumables, and services. The body fluids that are required for the procedure include blood, urine, saliva, stomach juice, tissue, others to detect and treat early gastric cancer and advanced gastric cancer.

The gastric cancer diagnostic procedure market covered in this report is segmented –

1) By Procedure Type: Endoscopic Procedure, Biopsy, Tissue tests, Lab tests, In-vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types

2) By Symptom Type: Symptomatic, Asymptomatic

3) By Offering Type: Instruments, Reagents and Consumables, Services

4) By Body Fluid Type: Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid

5) By Disease Indication: Early Gastric Cancer, Advanced Gastric Cancer

The gastric cancer diagnostic procedure market size has grown strongly in recent years. It will grow from $1.32 billion in 2023 to $1.43 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to innovations in biopsy techniques, increased research funding, evolution of biomarker discovery, improved pathological analysis, shifts in screening guidelines.

The gastric cancer diagnostic procedure market size is expected to see strong growth in the next few years. It will grow to $1.88 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rise in point-of-care testing, introduction of novel biomarkers, shift towards personalized medicine, adoption of next-generation sequencing, enhanced endoscopic imaging modalities. Major trends in the forecast period include integration of nanotechnology, adoption of big data analytics, application of microbiota analysis, increased patient-centric approaches, role of telehealth in diagnostics.

Gastrointestinal Disease Prevalence Propels Growth In The Gastric Cancer Diagnostic Procedure Market

The increasing prevalence of gastrointestinal diseases is driving the growth of the gastric cancer diagnostic procedure market going forward. Gastrointestinal disorders refer to illnesses affecting the digestive system's many sections and the supporting organs, including the liver and pancreas. A gastric cancer diagnostic procedure is used to treat stomach cancer which treats gastric cancer such as endoscopic and biopsy. Hence, the growing incidence of gastrointestinal diseases is fueling the expansion of the gastric cancer diagnostic procedure market. For instance, in August 2022, according to the report published by GI Associates & Endoscopy Center, a US-based medical facility specializing in gastroenterology services, a study that included 73,076 people from 33 nations, 40% of the subjects suffered from a functional gastrointestinal illness. Therefore, the increasing prevalence of gastrointestinal diseases contributes to the growth of the gastric cancer diagnostic procedure market.

Impact Of Smoking Epidemic On Gastric Cancer Diagnostic Procedures Market

The rising surge in smoking is expected to propel the growth of the gastric cancer diagnostic procedure market going forward. Smoking refers to the act of inhaling and exhaling the smoke produced by burning tobacco or other substances. Gastric cancer diagnostic procedures, can be crucial for individuals with a history of smoking or those at risk of smoking-related cancers for early detection, identification of precancerous lesions, helps in developing personalized and tailored treatment plans, facilitate communication and coordination, and can provide a comprehensive assessment of the gastric mucosa and surrounding tissues. For instance, in July 2023, according to a report shared by The World Health Organization, a Switzerland-based intergovernmental organization, more than 8 million people are killed by tobacco each year, including 1.3 million non-smokers who inhale second-hand smoke. Therefore, the rising surge in smoking is driving the growth of the gastric cancer diagnostic procedure market.

Major companies operating in the gastric cancer diagnostic procedure market report are Pfizer Inc., Johnson & Johnson Co, F. Hoffmann La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories Inc., Sanofi SA, Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., AdventHealth, Atrium Health, Astellas Pharma Inc., Bausch Health Companies Inc., Agilent Technologies Inc., Ipsen Pharma, Hartford HealthCare, Myriad Genetics Inc., Myriad Genetics Inc., NovoCure Limited, Foundation Medicine Inc., Biocept Inc.

Revolutionizing Gastric Cancer Diagnosis Through The Impact Of Cutting-Edge Technologies In The Diagnostic Market

Technological advancements are a key trend gaining popularity in the gastric cancer diagnostic market. Major companies operating in the gastric cancer diagnostic market are adopting new technologies to sustain their position in the market. For instance, in June 2022, Ibex Medical Analytics, an Israel-based AI-powered diagnostics provider for health organizations, launched Galen Gastric, the world's first AI-powered solution for gastric cancer detection. Galen Gastric is an integrated diagnostic tool that helps pathologists identify stomach cancer, H. pylori, and other significant clinical findings while also facilitating quicker turnaround times and improved diagnostic workflows.

Innovative Advances In Gastric Cancer Diagnostic Technologies Through The Role Of Tissue Staining Platforms

Major companies operating in the gastric cancer diagnostic procedure market are focusing on innovative products such as tissue staining platform to drive revenues in their market. Tissue staining platform is intended to provide fast and precise test findings, enabling medical professionals to decide on patient care in a timely manner. For instance, in June 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company launched benchmark ultra plus system. It is based on the well-proven technology of the benchmark ultra system and offers an unparalleled, fully-automated workflow for immunohistochemistry (IHC) and in-situ hybridization (ISH) slide staining. It provides an improved lab experience and an optimized workflow with adaptable solutions. A retractable work surface, improved sliding drawers to reduce fluid ingress/egress, new indicator lights, and remote monitoring via a linked device are just a few of the cutting-edge innovations that the system includes in response to user feedback. It offers an efficient workflow, testing efficiency, and ecologically friendly features.

Amgen's Strategic Acquisition Of Five Prime Therapeutics Is A Boost For Gastric Cancer Diagnostics And Global Expansion

In April 2021, Amgen, a US-based biopharmaceutical company, acquired Five Prime Therapeutics for $1.9 billion. This acquisition helps Amgen bring innovative, best-in-class diagnostic products to market, fuels companies' growth in gastric cancer diagnostics, also supports Amgen's international expansion strategy. Five Prime Therapeutics is a US-based clinical-stage biotechnology company that offers gastric cancer diagnostic services.

North America was the largest region in the gastric cancer diagnostics procedure market in 2023. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastric cancer diagnostic procedure market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastric cancer diagnostics procedure market includes revenues earned by entities that provide diagnostic procedures such as surgery, chemotherapy, and radiation therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The gastric cancer diagnostic procedure market research report is one of a series of new reports from The Business Research Company that provides gastric cancer diagnostic procedure market statistics, including the gastric cancer diagnostic procedure industry's global market size, regional shares, competitors with a gastric cancer diagnostic procedure market share, detailed gastric cancer diagnostic procedure market segments, market trends, and opportunities, and any further data you may need to thrive in the gastric cancer diagnostic procedure industry. This gastric cancer diagnostic procedure market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Gastric Cancer Diagnostic Procedure Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $1.43 billion
Revenue Forecast In 2033 $1.88 billion
Growth Rate CAGR of 7.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Procedure Type: Endoscopic Procedure, Biopsy, Tissue tests, Lab tests, In-vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types
2) By Symptom Type: Symptomatic, Asymptomatic
3) By Offering Type: Instruments, Reagents and Consumables, Services
4) By Body Fluid Type: Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid
5) By Disease Indication: Early Gastric Cancer, Advanced Gastric Cancer
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Johnson & Johnson Co; F. Hoffmann La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Novartis AG; Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; AstraZeneca plc; Abbott Laboratories Inc.; Sanofi SA; Eli Lilly and Company; Otsuka Pharmaceutical Co Ltd.; AdventHealth; Atrium Health; Astellas Pharma Inc; Bausch Health Companies Inc.; Agilent Technologies Inc.; Ipsen Pharma; Hartford HealthCare; Myriad Genetics Inc.; Myriad Genetics Inc.; NovoCure Limited; Foundation Medicine Inc.; Biocept Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Gastric Cancer Diagnostic Procedure Market Characteristics

    3. Gastric Cancer Diagnostic Procedure Market Trends And Strategies

    4. Gastric Cancer Diagnostic Procedure Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Gastric Cancer Diagnostic Procedure Market Size and Growth

    5.1. Global Gastric Cancer Diagnostic Procedure Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Gastric Cancer Diagnostic Procedure Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Gastric Cancer Diagnostic Procedure Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Gastric Cancer Diagnostic Procedure Market Segmentation

    6.1. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Endoscopic Procedure

    Biopsy

    Tissue tests

    Lab tests

    In-vitro Diagnostic Tests

    Imaging Tests

    Molecular Diagnostics

    Multiplexing Molecular Diagnostics

    Immunoassays

    Other Procedure Types

    6.2. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Symptomatic

    Asymptomatic

    6.3. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Instruments

    Reagents and Consumables

    Services

    6.4. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Body Fluid Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Blood

    Urine

    Saliva

    Stomach Juice

    Tissue

    Other Body Fluid

    6.5. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Early Gastric Cancer

    Advanced Gastric Cancer

    7. Gastric Cancer Diagnostic Procedure Market Regional And Country Analysis

    7.1. Global Gastric Cancer Diagnostic Procedure Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Gastric Cancer Diagnostic Procedure Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Gastric Cancer Diagnostic Procedure Market

    8.1. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Gastric Cancer Diagnostic Procedure Market

    9.1. China Gastric Cancer Diagnostic Procedure Market Overview

    9.2. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Gastric Cancer Diagnostic Procedure Market

    10.1. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Gastric Cancer Diagnostic Procedure Market

    11.1. Japan Gastric Cancer Diagnostic Procedure Market Overview

    11.2. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Gastric Cancer Diagnostic Procedure Market

    12.1. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Gastric Cancer Diagnostic Procedure Market

    13.1. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Gastric Cancer Diagnostic Procedure Market

    14.1. South Korea Gastric Cancer Diagnostic Procedure Market Overview

    14.2. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Gastric Cancer Diagnostic Procedure Market

    15.1. Western Europe Gastric Cancer Diagnostic Procedure Market Overview

    15.2. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Gastric Cancer Diagnostic Procedure Market

    16.1. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Gastric Cancer Diagnostic Procedure Market

    17.1. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Gastric Cancer Diagnostic Procedure Market

    18.5. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Gastric Cancer Diagnostic Procedure Market

    19.9. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Gastric Cancer Diagnostic Procedure Market

    20.13. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Gastric Cancer Diagnostic Procedure Market

    21.1. Eastern Europe Gastric Cancer Diagnostic Procedure Market Overview

    21.2. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Gastric Cancer Diagnostic Procedure Market

    22.1. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Gastric Cancer Diagnostic Procedure Market

    23.1. North America Gastric Cancer Diagnostic Procedure Market Overview

    23.2. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Gastric Cancer Diagnostic Procedure Market

    24.1. USA Gastric Cancer Diagnostic Procedure Market Overview

    24.2. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Gastric Cancer Diagnostic Procedure Market

    25.1. Canada Gastric Cancer Diagnostic Procedure Market Overview

    25.2. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Gastric Cancer Diagnostic Procedure Market

    26.1. South America Gastric Cancer Diagnostic Procedure Market Overview

    26.2. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Gastric Cancer Diagnostic Procedure Market

    27.1. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Gastric Cancer Diagnostic Procedure Market

    28.1. Middle East Gastric Cancer Diagnostic Procedure Market Overview

    28.2. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Gastric Cancer Diagnostic Procedure Market

    29.1. Africa Gastric Cancer Diagnostic Procedure Market Overview

    29.2. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Gastric Cancer Diagnostic Procedure Market Competitive Landscape And Company Profiles

    30.1. Gastric Cancer Diagnostic Procedure Market Competitive Landscape

    30.2. Gastric Cancer Diagnostic Procedure Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson Co

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. F. Hoffmann La Roche Ltd.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Merck & Co. Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Bayer AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Gastric Cancer Diagnostic Procedure Market Other Major And Innovative Companies

    31.1. Novartis AG

    31.2. Bristol-Myers Squibb Company

    31.3. Thermo Fisher Scientific Inc.

    31.4. AstraZeneca plc

    31.5. Abbott Laboratories Inc.

    31.6. Sanofi SA

    31.7. Eli Lilly and Company

    31.8. Otsuka Pharmaceutical Co Ltd.

    31.9. AdventHealth

    31.10. Atrium Health

    31.11. Astellas Pharma Inc

    31.12. Bausch Health Companies Inc.

    31.13. Agilent Technologies Inc.

    31.14. Ipsen Pharma

    31.15. Hartford HealthCare

    32. Global Gastric Cancer Diagnostic Procedure Market Competitive Benchmarking

    33. Global Gastric Cancer Diagnostic Procedure Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Gastric Cancer Diagnostic Procedure Market

    35. Gastric Cancer Diagnostic Procedure Market Future Outlook and Potential Analysis

    35.1 Gastric Cancer Diagnostic Procedure Market In 2028 - Countries Offering Most New Opportunities

    35.2 Gastric Cancer Diagnostic Procedure Market In 2028 - Segments Offering Most New Opportunities

    35.3 Gastric Cancer Diagnostic Procedure Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Body Fluid Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Gastric Cancer Diagnostic Procedure Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Gastric Cancer Diagnostic Procedure Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: Pfizer Inc. Financial Performance
  • Table 77: Johnson & Johnson Co Financial Performance
  • Table 78: F. Hoffmann La Roche Ltd. Financial Performance
  • Table 79: Merck & Co. Inc. Financial Performance
  • Table 80: Bayer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Body Fluid Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Gastric Cancer Diagnostic Procedure Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Gastric Cancer Diagnostic Procedure Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: Pfizer Inc. Financial Performance
  • Figure 77: Johnson & Johnson Co Financial Performance
  • Figure 78: F. Hoffmann La Roche Ltd. Financial Performance
  • Figure 79: Merck & Co. Inc. Financial Performance
  • Figure 80: Bayer AG Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Commercial Vehicle Global Market Report 2024 – By Type (Light Commercial Vehicle, Heavy Trucks, Buses And Coaches), By Fuel Type (Gasoline, Diesel, Other Fuel Types), By Application (Mining & Construction, Logistics, Passenger Transportation, Other Applications), By Propulsion Type (IC Engine, Electric Vehicle) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Mobility Aids And Transportation Equipment Global Market Report 2024 – By Type (Electrically Powered Wheelchairs, Manual Wheelchairs, Walking Aids, Mobility Scooters, Stretchers, Stair Lifts), By Age Group (Mobility Aids for Children, Mobility Aids for Elderly), By End User (Hospital, Clinic, Household) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Electric Motors Global Market Report 2024 – By Type (Alternate Current (AC) Motor, Direct Current (AC) Motor, Hermetic Motor), By Output Power (Integral Horsepower (IHP), Fractional Horsepower (FHP)), By Application (Industrial Machinery, Motor Vehicle, HVAC Equipment, Aerospace & Transportation, Household Appliances, Other Commercial Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Machinery Global Market Report 2024 – By Type (Automatic, Semi-Automatic), By Capacity (Small, Medium, Large), By Application (Automotive, Precision Engineering, Transport, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Passenger Air Transport Global Market Report 2024 – By Type (Domestic Air Passengers, International Air Passengers), By Class (Business Class, Economy Class, First Class), By End-Use (Private, Commercial) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Chartered Air Transport Global Market Report 2024 – By Type (Passenger Chartered Air Transport, Freight Chartered Air Transport, Other Chartered Air Transport), By Application (Private Charter, Affinity, Single Entity, Public Charter), By End Use (Wealthy Individuals, Sports Teams, Large Corporation) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Transportation Manufacturing Global Market Report 2020 - By Type (Motor Vehicles, Motor Vehicle Parts Manufacturing, Aircraft And Components Manufacturing, Space, Military, & Other Transportation, Ship And Boat Building And Train), By Geography (North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East And Africa), COVID-19 Impact
View Report
Truck Transportation Global Market Report 2020 - By Type (General Freight Trucking, Specialized Freight Trucking Local General Freight Trucking, Long-Distance General Freight Trucking, Automobiles And Heavy Equipment, Bulk Liquids, Dry Bulk Materials, Forest Products, Refrigerated Goods)
View Report

Frequently Asked Questions

What is the definition of the gastric cancer diagnostic procedure market?

Gastric cancer diagnostic procedure refers to a technique of identification and medication to treat cancer cells that grow in the stomach. It is used to diagnose stomach cancer. For further insights on the gastric cancer diagnostic procedure market, request a sample here

How will the gastric cancer diagnostic procedure market drivers and restraints affect the gastric cancer diagnostic procedure market dynamics? What forces will shape the gastric cancer diagnostic procedure industry going forward?

The gastric cancer diagnostic procedure market major growth driver - Gastrointestinal Disease Prevalence Propels Growth In The Gastric Cancer Diagnostic Procedure Market. For further insights on the gastric cancer diagnostic procedure market, request a sample here

What is the forecast market size or the forecast market value of the gastric cancer diagnostic procedure market?

The gastric cancer diagnostic procedure market size has grown strongly in recent years. It will grow from $1.32 billion in 2023 to $1.43 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to innovations in biopsy techniques, increased research funding, evolution of biomarker discovery, improved pathological analysis, shifts in screening guidelines.. The gastric cancer diagnostic procedure market size is expected to see strong growth in the next few years. It will grow to $1.88 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rise in point-of-care testing, introduction of novel biomarkers, shift towards personalized medicine, adoption of next-generation sequencing, enhanced endoscopic imaging modalities.. Major trends in the forecast period include integration of nanotechnology, adoption of big data analytics, application of microbiota analysis, increased patient-centric approaches, role of telehealth in diagnostics.. For further insights on the gastric cancer diagnostic procedure market, request a sample here

How is the gastric cancer diagnostic procedure market segmented?

The gastric cancer diagnostic procedure market is segmented
1) By Procedure Type: Endoscopic Procedure, Biopsy, Tissue tests, Lab tests, In-vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types
2) By Symptom Type: Symptomatic, Asymptomatic
3) By Offering Type: Instruments, Reagents and Consumables, Services
4) By Body Fluid Type: Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid
5) By Disease Indication: Early Gastric Cancer, Advanced Gastric CancerFor further insights on the gastric cancer diagnostic procedure market, request a sample here

Which region has the largest share of the gastric cancer diagnostic procedure market? What are the other regions covered in the report?

North America was the largest region in the gastric cancer diagnostics procedure market in 2023. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the gastric cancer diagnostic procedure market, request a sample here.

Who are the major players in the gastric cancer diagnostic procedure market?

Major companies operating in the gastric cancer diagnostic procedure market report are Pfizer Inc., Johnson & Johnson Co, F. Hoffmann La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories Inc., Sanofi SA, Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., AdventHealth, Atrium Health, Astellas Pharma Inc, Bausch Health Companies Inc., Agilent Technologies Inc., Ipsen Pharma, Hartford HealthCare, Myriad Genetics Inc., Myriad Genetics Inc., NovoCure Limited, Foundation Medicine Inc., Biocept Inc. For further insights on the gastric cancer diagnostic procedure market, request a sample here.

What are the key trends in the gastric cancer diagnostic procedure market?

Major trend in the gastric cancer diagnostic procedure market - Revolutionizing Gastric Cancer Diagnosis Through The Impact Of Cutting-Edge Technologies In The Diagnostic Market. For further insights on the gastric cancer diagnostic procedure market, request a sample here.

What are the major opportunities in the gastric cancer diagnostic procedure market? What are the strategies for the gastric cancer diagnostic procedure market?

For detailed insights on the major opportunities and strategies in the gastric cancer diagnostic procedure market, request a sample here.

How does the gastric cancer diagnostic procedure market relate to the overall economy and other similar markets?

For detailed insights on gastric cancer diagnostic procedure market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the gastric cancer diagnostic procedure industry?

For detailed insights on the mergers and acquisitions in the gastric cancer diagnostic procedure industry, request a sample here.

What are the key dynamics influencing the gastric cancer diagnostic procedure market growth? SWOT analysis of the gastric cancer diagnostic procedure market.

For detailed insights on the key dynamics influencing the gastric cancer diagnostic procedure market growth and SWOT analysis of the gastric cancer diagnostic procedure industry, request a sample here.